SPPI Spectrum Pharmaceuticals Inc

Price (delayed)

$0.88

Market cap

$158.48M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.86

Enterprise value

$79.8M

Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business ...

Highlights
The company's EPS rose by 26% YoY and by 16% QoQ
SPPI's net income is up by 13% QoQ and by 11% YoY
Spectrum Pharmaceuticals's equity has shrunk by 55% YoY but it has increased by 16% QoQ
The quick ratio fell by 35% YoY but it rose by 20% QoQ

Key stats

What are the main financial stats of SPPI
Market
Shares outstanding
180.09M
Market cap
$158.48M
Enterprise value
$79.8M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.82
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$138.35M
EBITDA
-$136.47M
Free cash flow
-$115.48M
Per share
EPS
-$0.86
Free cash flow per share
-$0.68
Book value per share
$0.31
Revenue per share
$0
TBVPS
$0.59
Balance sheet
Total assets
$100.05M
Total liabilities
$44.8M
Debt
$0
Equity
$55.26M
Working capital
$53.97M
Liquidity
Debt to equity
0
Current ratio
2.38
Quick ratio
2.29
Net debt/EBITDA
0.58
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-103.6%
Return on equity
-190.3%
Return on invested capital
N/A
Return on capital employed
-227.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SPPI stock price

How has the Spectrum Pharmaceuticals stock price performed over time
Intraday
-1.18%
1 week
10.85%
1 month
24.01%
1 year
-78.05%
YTD
-30.71%
QTD
-31.78%

Financial performance

How have Spectrum Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$128.08M
Net income
-$138.37M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 26% YoY and by 13% from the previous quarter
SPPI's net income is up by 13% QoQ and by 11% YoY

Growth

What is Spectrum Pharmaceuticals's growth rate over time

Valuation

What is Spectrum Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.82
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 26% YoY and by 16% QoQ
Spectrum Pharmaceuticals's equity has shrunk by 55% YoY but it has increased by 16% QoQ
SPPI's price to book (P/B) is 40% lower than its last 4 quarters average of 4.7 and 31% lower than its 5-year quarterly average of 4.1

Efficiency

How efficient is Spectrum Pharmaceuticals business performance
The return on equity has dropped by 69% year-on-year and by 7% since the previous quarter
Spectrum Pharmaceuticals's return on assets has decreased by 34% YoY

Dividends

What is SPPI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SPPI.

Financial health

How did Spectrum Pharmaceuticals financials performed over time
Spectrum Pharmaceuticals's total assets is 123% higher than its total liabilities
Spectrum Pharmaceuticals's total assets has decreased by 44% YoY and by 10% QoQ
The quick ratio fell by 35% YoY but it rose by 20% QoQ
Spectrum Pharmaceuticals's debt is 100% less than its equity
Spectrum Pharmaceuticals's equity has shrunk by 55% YoY but it has increased by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.